Mumbai, May 29 -- The scrip was listed at Rs 452, a 31.78% premium to the initial public offer (IPO) price. The stock is currently down 1.31% over its listing price.

The counter hit a high of Rs 460 and a low of Rs 431. About 31.26 lakh shares of the company changed hands at the counter.

Q-Line Biotech's IPO was subscribed 95.31 times. The issue opened for bidding on 21 May 2026 and it closed on 25 May 2026. The price band of the IPO was fixed between Rs 326 to Rs 343 per share.

The IPO comprised fresh issue of 62,53,200 equity shares. The promoter and promoter group shareholding diluted to 67.51% from 92.24% pre-issue.

The company intends to utilize the net proceeds to meet working capital requirements, repayment of certain borrowing...